MYC (8q24) Gene Rearrangement by FISH

Also known as: MYC FISH

Clinical Use

Use

This test facilitates the diagnosis of Burkitt's lymphoma (BL) and B-cell lymphoma with features intermediate between BL and diffuse large B-cell lymphoma (DLBCL). It detects all MYC rearrangements, including translocations t(8;14), t(2;8), and t(8;22). MYC rearrangement is seen in a variety of B-cell lymphomas, including 'double hit' or 'triple hit' lymphomas, and results should be correlated with clinical, morphologic, and immunophenotypic data.

Special Instructions

Not provided.

Limitations

This test is expected to detect 100 percent of MYC rearrangements in patients with MYC-rearranged lymphomas, except for rare instances of cryptic rearrangements. The use of this assay on decalcified tissues has not been validated, so results should be interpreted with caution. It has not been cleared or approved by the U.S. Food and Drug Administration and was developed by ARUP Laboratories.

Test Details

New York Approved

Methodology

Chromosomal / Cytogenetics (FISH)

Biomarkers

No genes

Gene

Rearrangement

Other • Binary (Detected / Not Detected)

LOINC Codes

Result Codes

81304-8 - Struct var analysis method
78236-7 - Cells.IGH rear/Cells cnt NFr Bld/T FISH

Result Turnaround Time

3-7 days

Specimen

Tissue (FFPE)

Volume

Not provided

Minimum Volume

Not provided

Container

Tissue block or 5 unstained slides

Collection Instructions

Formalin fix (10 percent neutral buffered formalin) and paraffin-embed specimen. Use ARUP supply #47808 for transportation.

Storage Instructions

Protect paraffin block from excessive heat. Transport tissue block or 5 unstained slides in a tissue transport kit. Use a cooled container during summer months.

Causes for Rejection

Paraffin block with no tumor tissue remaining. Specimens fixed in any fixative other than 10 percent neutral buffered formalin. Decalcified specimens.